N
Nofar Atari
Researcher at United States Public Health Service
Publications - 24
Citations - 191
Nofar Atari is an academic researcher from United States Public Health Service. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications receiving 43 citations.
Papers
More filters
Journal ArticleDOI
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Yaniv Lustig,Yaniv Lustig,Neta S. Zuckerman,Ital Nemet,Nofar Atari,Limor Kliker,Gili Regev-Yochay,Gili Regev-Yochay,Einav Sapir,Einav Sapir,Orna Mor,Orna Mor,Sharon Alroy-Preis,Ella Mendelson,Ella Mendelson,Michal Mandelboim,Michal Mandelboim +16 more
TL;DR: In this article, micro-neutralization assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising titres compared with the original virus.
Journal ArticleDOI
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
L. Kliker,Neta S. Zuckerman,Nofar Atari,Noam Barda,Mayan Gilboa,Ital Nemet,Bayan Abd Elkader,Ilana S. Fratty,Hanaa Jaber,Ella Mendelson,Sharon Alroy-Preis,Yitshak Kreiss,Gili Regev-Yochay,Michal Mandelboim +13 more
TL;DR: Omicron breakthrough infection in individuals vaccinated three or four times before infection resulted in increased neutralising antibodies against the WT virus, and the fourth vaccine dose did not further improve the neutralising efficiency over the third dose against all Omicron variants.
Journal ArticleDOI
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
Neta S. Zuckerman,Ital Nemet,Limor Kliker,Nofar Atari,Yaniv Lustig,Yaniv Lustig,Efrat Bucris,Miranda Geva,Reut Sorek-Abramovich,Chen Weiner,Nir Rainy,Adina Bar-Chaim,Patricia Benveniste-Levkovitz,Ramzia Abu Hamed,Gili Regev-Yochay,Gili Regev-Yochay,Ofra Hevkin,Orna Mor,Orna Mor,Sharon Alroy-Preis,Ella Mendelson,Ella Mendelson,Michal Mandelboim,Michal Mandelboim +23 more
TL;DR: The SARS-CoV-2 Lambda (Pango lineage designation C.37) variant of interest, initially identified in Peru, has spread to additional countries.
Posted ContentDOI
P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants
Alona Kuzmina,Nofar Atari,Aner Ottolenghi,D. V. Korovin,Ido Cohen lass,Benyamin Rosental,Elli Rosenberg,Michal Mandelboim,Ran Taube +8 more
TL;DR: The efficiency of the third dose of the Pfizer vaccine against SARS CoV-2 is waned, and cannot neutralize Omicron, and it is verified that the P681 position of the viral spike dictates fusogenicity and syncytia formation.
Journal ArticleDOI
Human Metapneumovirus prevalence during 2019-2021 in Israel is influence by the COVID-19 pandemic.
Michal Stein,Hodaya Cohen,Ital Nemet,Nofar Atari,L. Kliker,Ilana S. Fratty,Efrat Bucris,Miranda Geva,Ella Mendelson,Neta S. Zuckerman,Michal Mandelboim +10 more
TL;DR: In this article , the authors compared infection rates and circulating subtypes of human metapneumovirus (hMPV) before (2019-2020) and after the emergence of coronavirus disease 2019 (COVID-19) (2021) in Israel.